nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0687	0.0687	CcSEcCtD
Etravirine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0462	0.0462	CcSEcCtD
Etravirine—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0372	0.0372	CcSEcCtD
Etravirine—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0368	0.0368	CcSEcCtD
Etravirine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0271	0.0271	CcSEcCtD
Etravirine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0253	0.0253	CcSEcCtD
Etravirine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0214	CcSEcCtD
Etravirine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0198	CcSEcCtD
Etravirine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0196	CcSEcCtD
Etravirine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0168	CcSEcCtD
Etravirine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0164	CcSEcCtD
Etravirine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0162	CcSEcCtD
Etravirine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0157	CcSEcCtD
Etravirine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0156	CcSEcCtD
Etravirine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0141	CcSEcCtD
Etravirine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Etravirine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Etravirine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Etravirine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Etravirine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0129	CcSEcCtD
Etravirine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0128	CcSEcCtD
Etravirine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Etravirine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0126	CcSEcCtD
Etravirine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0126	CcSEcCtD
Etravirine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0122	CcSEcCtD
Etravirine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.012	0.012	CcSEcCtD
Etravirine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0119	CcSEcCtD
Etravirine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Etravirine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Etravirine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Etravirine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Etravirine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Etravirine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Etravirine—Tension—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Etravirine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Etravirine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Etravirine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Etravirine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Etravirine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Etravirine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Etravirine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Etravirine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Etravirine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00984	0.00984	CcSEcCtD
Etravirine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0097	0.0097	CcSEcCtD
Etravirine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00966	0.00966	CcSEcCtD
Etravirine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0095	0.0095	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00946	0.00946	CcSEcCtD
Etravirine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00941	0.00941	CcSEcCtD
Etravirine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00932	0.00932	CcSEcCtD
Etravirine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00921	0.00921	CcSEcCtD
Etravirine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00907	0.00907	CcSEcCtD
Etravirine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00899	0.00899	CcSEcCtD
Etravirine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00896	0.00896	CcSEcCtD
Etravirine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00894	0.00894	CcSEcCtD
Etravirine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00887	0.00887	CcSEcCtD
Etravirine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00883	0.00883	CcSEcCtD
Etravirine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00871	0.00871	CcSEcCtD
Etravirine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00826	0.00826	CcSEcCtD
Etravirine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0082	CcSEcCtD
Etravirine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00812	0.00812	CcSEcCtD
Etravirine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00794	0.00794	CcSEcCtD
Etravirine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00789	0.00789	CcSEcCtD
Etravirine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Etravirine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00781	CcSEcCtD
Etravirine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00781	CcSEcCtD
Etravirine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00753	0.00753	CcSEcCtD
Etravirine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00747	CcSEcCtD
Etravirine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00722	0.00722	CcSEcCtD
Etravirine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00722	0.00722	CcSEcCtD
Etravirine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00673	CcSEcCtD
Etravirine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00655	0.00655	CcSEcCtD
Etravirine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00625	CcSEcCtD
Etravirine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00604	CcSEcCtD
Etravirine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00581	CcSEcCtD
Etravirine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00576	CcSEcCtD
Etravirine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00575	CcSEcCtD
Etravirine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00572	CcSEcCtD
Etravirine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00543	CcSEcCtD
